Behavioral effects of HT-90B, a putative novel anxiolytic agent with potent antidepressive activity

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 20, Issue 1, 1996, Pages 129-145

  Inagawa, Kentaro ^a   Tameda, Chiho ^a   Uchida, Haruhisa ^a   Miyauchi, Tatsuo ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Anti depressive anxiolytic; Forced swim test; Serotonin; Water licking conflict test

Indexed keywords

ANXIOLYTIC AGENT; BUSPIRONE; DESIPRAMINE; DIAZEPAM; N [2 [(8 METHYL 1,4 BENZODIOXAN 2 YLMETHYL)AMINO]ETHYL] 1 ADAMANTANECARBOXAMIDE; UNCLASSIFIED DRUG; ADAMANTANE; ANTIDEPRESSANT AGENT; DRUG DERIVATIVE; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; DEPRESSION; DRUG RESPONSE; DRUG STRUCTURE; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; ANIMAL; ANIMAL BEHAVIOR; DOSE RESPONSE; DRUG EFFECT; LOCOMOTION; SPRAGUE DAWLEY RAT;

ADAMANTANE; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LOCOMOTION; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN ANTAGONISTS;

EID: 0029658103     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-5846(95)00300-2     Document Type: Article

References (35)

1. 2 receptors in the rat medial prefrontal cortex: Iontophoretic studies. Soc. Neurosci. Abst. 18: 1380.
2. BALSTER, R. L. (1991) Preclinical studies of the abuse potential of buspirone. In: Buspirone: Mechanisms and Clinical Aspects, G. Tunnicliff, A. S. Eison, and D. P. Talor (Eds.), pp 97-107, Academic Press, San Diego.
3. BARRETT, J. E. and WITKIN, J.M. (1991) Buspirone in animal models in anxiety. In: Buspirone: Mechanisms and Clinical Aspects, G. Tunnicliff, A. S. Eison, and D. P. Talor (Eds.), pp 37-79, Academic Press, San Diego.
4. BENEKE, M., KUMMEL, B., ROAD, I.S. and SPECHTMEYER, H. (1988) Treatment of anxiety neurosis with ipsapirone. Psychopharmacol. 96(Suppl): S353.
5. BEVEN, P. and COOLS, A. R., and ARCHER, T.(1989) Behavioral Pharmacology of 5-HT., Lawrence Erlbaum Associates, Hillsdale, New Jersey
6. BLACKSHEAR, M. A. and SANDERS-BUSH, E. (1982) Serotoninreceptor sensitivity after acute and chronic treatment with Mianserin. J. Parmacol. Exp. Ther. 221: 303-308.
7. BLIER, P., STEINBERG, S., CHPUT, Y., and De MONTIGNY, C. (1989) Electrophysiological assessment of putative antagonist of 5-hydroxytryptamine receptors: a single-cell study in the rat dorsal nucleus. Can. J. Physiol. Pharmacol. 67: 98-105.
8. 1A receptor agonist. Eur. J. Pharmacol. 144: 223-229
9. 1A receptors. Eur. J. Pharmacol. 253: 139-147.
10. CHARNEY, D. S. and DELGADO, P. L. (1992) Current concepts of the role of serotonin functioning in depression and anxiety. In Langer, S, Brunello, N., Racagni, G., and Mendelwicz, J. (Eds.) Serotonin receptor subtypes. Karger, Basel, pp.89-104.
11. 1A receptors in the antidepressant-like activity of gepirone in the forced swim test in rats. Neuropharmacol. 30:711-717.
12. CHOPIN, P. and BRILEY, M. (1987) Animal model of anxiety: The effects of compounds that modify 5-HT neurotransmission. Trnds Pharmacol. Sci. 8: 383-385.
13. COOK, L. and DAVIDSON, A. B. (1973) Effects of behaviorally active drugs in a conflict-punishment procedure in rats. In: The Benzodiazepines, S. Garattini, E. Mussini, and L. O. Randall (Eds.), pp. 327-345, Raven Press, New York.
14. 1A ligand with both antidepressant and anxiolytic properties. Psychopharmacol. Bull. 24: 164-167.
15. DEAKIN, J. F. W. (1988) 5-HT receptor subtypes in depression. In: Behavioral Pharmacology of 5-HT, Bevan, P., Cools, A. R., and T. Archer (Eds.), pp. 179-204, Lawrence Erlbaum Associations, Hillsdale, NJ.
16. GLENNON, R. A. (1990) Sereotonin receptors: Clinical implications. Neurosci. Biobehav. Rev. 14: 35-47.
17. 2receptors in the rat medial prefrontal cortex: Behavioral studies. Soc. Neurosci. Abst. 18: 1380
18. KITADA, T., MIYAUCHI, T., SATOH, A. and SATOH, S. (1981) Effects of anti-depressants in the rat forced swimming test. Eur. J. Pharmacol. 72: 145-152.
19. LAKOSKI, J. M. and AGHAJANIAN, G. K. (1985) Effects of ketanserin on neural response to serotonin in the prefrontal cortex, lateral geniculate and dorsal raphe nucleus. Neurophaemacol. 24: 4265-4273.
20. 1A rceptors.Br. J. Pharmacol. 108: 669-677.
21. MCMILLEN, B. A. (1991) Buspirone and the dopaminergic system. In: Buspirone: Mechanisms and Clinical Aspects, G. Tunnicliff, A. S. Eison, and D. P. Talor (Eds.), pp 163-176, Academic Press, San Diego.
22. PEROUTKA, S. J. and SNYDER, S.H. (1980) Long-term antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding. Science, 210: 88-90.
23. PORSILT, R. D. (1985) Animal model of affective disorders. In: Pharmacotherapy of affective disorders: Theory and Practice, W. G. Dewhurst and G. B. Baker (Eds), pp. 108-150. New York University Press, New York.
24. PORSOLT, R. D., BERTIN, A. and JAFRE, M. (1977a) Behavioral despair in mice: A primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. :229 327-336.
25. PORSILT, R. D., LE PICHON, M., and JAFRE, M. (1977b) Depression: A new animal model sensitive to antidepressants. Nature, 266: 730-732.
26. PORSOLT, R., ANTON, G., BLAVET, N., and JAFRE, M., (1978) Behavioural despair in rats: A new model senstive to antidepressant treatments. Eur. J. Pharmacol. 47:379-391.
27. PORSOLT, R. D., LENEGRE, A., and MCARTHER, R. A. (1991) model Pharmacological of depression. In: Animal model in psychopharmacology, B. Olivier, J. Slanger, J. and J. Mos (Eds), pp.137-159, Birkhaeuser Verlag, Basle.
28. PRZEGALINSKI, E., TATARCZYNSKA, E., and CHOJNACKA-WOJCIK, E. (1990) Amtidepressant-like activity of ipsapirone, buspirone, and gepirone in the forced swimming test in rats pretreated with proadifen. Eur. J. Pharmacol. :183 1906P
29. REYNTJENS, A., GELDERS, Y. G., HOPPENBROUWERS, J. A. and BUSSCHE, G. (1986) Thymosthenic effects of retamserin (R55667), a centrally acting serotonin-S2 receptor blocker. Drug Dev. Res. 8: 205-211.
30. ROBINSON, D. S., ALMS, D. R., SHROTRIYA, R. C., MESSINA, M. and WICKRAMARATNE, M. (1989) Serotonergic anxiolytics and treatment of depression. Psychopathol. 22(Suppl): 27-36.
31. TATARCZYNSKAE, and CHOJNACKA-WOJCIK, E. (1989) Effects of 8-OH-DPAT and ipsapirone in the forced swim tests used for evaluation of the antidepressant action. Pharmacol. Biochem Behav. 41:321-330.
32. 2 Receptor Antagonist. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 19 (in press)
33. VOGEL, J. R., BEER, B., and CLODY, D. E. (1971) A simple reliable conflict procedure for testing antianxiety agents. Psychopharmacol. 21: 1-7.
34. WEISS, S., SEBBE, M., KEMP, D.E., and BOCKAERT, J. (1986) Serotonin 5-HT1 receptors mediate inhibition of cyclic AMP production in neurons. Eur. J. Pharmacol. 120: 227-230.
35. 1A agonist measured with the forced swim test. Psychopharmacol. 101: 497-504